🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

Enrolling by InvitationNCT06847750

Elastography Ultrasound in Localized Scleroderma (Morphea) Study

🏥 The Hospital for Sick Children📍 1 site📅 Started Mar 2023View details ↗
RecruitingNCT05350761

Rare Tumors and Cancer Predisposition in Individuals and Families

👨‍⚕️ Sharon A Savage, M.D., National Cancer Institute (NCI)📍 2 sites📅 Started Mar 2023View details ↗
RecruitingNCT06337760

YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.

👨‍⚕️ Francesca Spada, MD, Istituto Europeo di Oncologia📍 1 site📅 Started Mar 2023View details ↗
Phase 1, PHASE2RecruitingNCT05643742

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

👨‍⚕️ Melanie Allen, M.Sc., CRISPR Therapeutics📍 7 sites📅 Started Mar 2023View details ↗
NARecruitingNCT06682819

Metabolomics Analysis According to the Retinal Nerve Fiber Layer in Patients With NOHL Mutations (MétabOCT)

👨‍⚕️ Christophe Orssaud, MD, Hopital Necker📍 1 site📅 Started Mar 2023View details ↗
RecruitingNCT06118229

A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients

👨‍⚕️ Jianxing He, M.D, The First Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Mar 2023View details ↗
Phase 4RecruitingNCT05644496

ZYNRELEF for Pain Management in Total Knee Arthroplasty

👨‍⚕️ Juan C Suarez, MD, Baptist Health South Florida📍 1 site📅 Started Mar 2023View details ↗
Phase 4RecruitingNCT05965284

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

👨‍⚕️ JIng Li, M.D., Peking Unione Mdecial College Hospital📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT06189820

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

🏥 Erasme University Hospital📍 1 site📅 Started Mar 2023View details ↗
Phase 1RecruitingNCT05526924

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

👨‍⚕️ Ari Rosenberg, MD, University of Chicago📍 1 site📅 Started Mar 2023View details ↗
Phase 3RecruitingNCT05744921

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 43 sites📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05686226

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

👨‍⚕️ Christian S Hinrichs, MD, Rutgers Cancer Institute📍 3 sites📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT06128278

Acute Equol Supplementation and Vascular Function in Women With and Without CKD

🏥 University of Colorado, Denver📍 1 site📅 Started Mar 2023View details ↗
RecruitingNCT06089096

Sleep Apnea and Cognitive Function in Subjects With Subjective or Mild Cognitive Impairment

👨‍⚕️ Sau Man Mary Ip, MD, School of Clinical Medicine, The University of Hong Kong📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT06511648

Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations

🏥 Spanish Oncology Genito-Urinary Group📍 23 sites📅 Started Mar 2023View details ↗
NARecruitingNCT04654000

Rheopheresis as Adjuvant Treatment of Calciphylaxis

👨‍⚕️ Arnaud Lionet, MD, University Hospital, Lille📍 29 sites📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT04128072

Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma

👨‍⚕️ Pablo Luis Ortiz Romero, Hospital Universitario 12 De Octubre,Madrid, Spain📍 13 sites📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05765825

Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

👨‍⚕️ You Lu, MD, West China Hospital📍 8 sites📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05742698

Nabilone for Agitation in Frontotemporal Dementia

🏥 Simon Ducharme, MD📍 7 sites📅 Started Mar 2023View details ↗
NARecruitingNCT05521776

Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)

👨‍⚕️ Catherine DENEUX, MD, PhD, Institut National de la Santé Et de la Recherche Médicale, France📍 22 sites📅 Started Mar 2023View details ↗
← PreviousPage 422 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →